Table 2.

Clinical features in cases and controls in the whole study population and association with CRC and/or IBD

Clinical featureFrequency of features in cases and controls in CRC/IBD datasetOR (95% CI) in multivariable analysis for:
Cases, n (%) n= 11 239Controls, n (%) n= 26 926Positive LR PPVa (95% CI)(95% CI)CRC/IBDIBDCRC
Symptoms
  Diarrhoea3047 (27.1)531 (2)13.8 (12.6 to 15)0.5 (0.5 to 0.6)8.9 (7.5 to 11)9.5 (7.9 to 12)7.7 (4.3 to 14)
  Abdominal pain3040 (27.1)1534 (5.7)4.8 (4.5 to 5)0.2 (0.2 to 0.2)3.9 (3.4 to 4.5)3.5 (3.0 to 4.1)6.0 (4.2 to 8.7)
  Rectal bleeding2654 (23.6)201 (0.8)31.6 (27.5 to 36.5)1.2 (1.1 to 1.4)42 (33 to 55)40 (31 to 53)54 (26 to 110)
  Change in bowel habit730 (6.5)65 (0.2)26.9 (20.9 to 34.6)1.0 (0.8 to 1.3)27 (19 to 38)22 (15 to 33)58 (21 to 160)
  Constipation471 (4.2)245 (0.9)aaaa7.9 (4.3 to 14)
  Nausea/vomiting540 (4.8)410 (1.5)aaaa2.7 (1.4 to 5.1)
  Rectal mass189 (1.7)9 (0.03)aaaa190 (51 to 720)
Investigations
  Raised inflammatory markers3115 (27.7)575 (2.1)13 (11.9 to 14.2)0.5 (0.5 to 0.6)5.4 (4.6 to 6.3)6.1 (5.1 to 7.3)3.1 (2.0 to 4.7)
  Low haemoglobin1802 (16)572 (2.1)7.6 (6.9 to 8.3)0.3 (0.3 to 0.3)2.5 (2.1 to 3.1)2.2 (1.8 to 2.8)5.2 (3.2 to 8.5)
  Raised platelets1678 (14.9)206 (0.8)19.5 (16.9 to 22.5)0.8 (0.7 to 0.9)4.4 (3.4 to 5.7)5.4 (4.0 to 7.2)a
  Raised white cell count1472 (13.1)488 (1.8)7.2 (6.5 to 8)0.3 (0.3 to 0.3)1.5 (1.3 to 1.9)1.7 (1.4 to 2.1)a
  Abnormal liver function1392 (12.4)1019 (3.8)3.3 (3 to 3.5)0.1 (0.1 to 0.1)1.4 (1.2 to 1.6)1.4 (1.2 to 1.7)a
  Low mean red cell volume1102 (9.8)290 (1.1)9.1 (8 to 10.3)0.4 (0.3 to 0.4)2.7 (2.1 to 3.5)2.4 (1.8 to 3.2)4.3 (2.3 to 8.0)
  • a Features that did not retain independent significance in multivariable analysis in the CRC/IBD population. All associations in the above table had a P-value of <0.001. CRC = colorectal cancer. IBD = inflammatory bowel disease. LR = likelihood ratio. PPV = positive predictive value.